Pergi ke luar talian dengan aplikasi Player FM !
TBT - Dermatomyositis and the HALT-IT Trial
Manage episode 419907813 series 3323674
Welcome back Rounds Table Listeners!
In this throwback episode, Drs. John and Mike Fralick discuss two papers – one, exploring IVIG in the treatment of dermatomyositis, and the second investigating the effect of tranexamic acid in patients with acute gastrointestinal bleeding.
- Trial of Intravenous Immune Globulin in Dermatomyositis (0:00 – 8:38).
- Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international, randomised, double-blind, placebo-controlled trial (8:38 – 18:04).
And for the Good Stuff:
- Alberta using humour to attract workers (18:04 – 18:50).
- CBME in Residency Education (18:50 – 21:02).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
346 episod
Manage episode 419907813 series 3323674
Welcome back Rounds Table Listeners!
In this throwback episode, Drs. John and Mike Fralick discuss two papers – one, exploring IVIG in the treatment of dermatomyositis, and the second investigating the effect of tranexamic acid in patients with acute gastrointestinal bleeding.
- Trial of Intravenous Immune Globulin in Dermatomyositis (0:00 – 8:38).
- Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international, randomised, double-blind, placebo-controlled trial (8:38 – 18:04).
And for the Good Stuff:
- Alberta using humour to attract workers (18:04 – 18:50).
- CBME in Residency Education (18:50 – 21:02).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
346 episod
Semua episod
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.